Lauren Feldman 7/15/2022 at 7:12 pm
FiercePharma (July 14, 2022) Pfizer’s Hospira recalls anesthetic after finding ‘visible’ particulate during annual inspection
Hospira, a subsidiary of Pfizer, issued a voluntary recall for one lot of the anesthetic propofol after discovering “a visible particulate” in a vial during an annual inspection. Propofol is generally used to induce and maintain anesthesia and sedation for patients undergoing surgery.
NPR (July 14, 2022) Animal rescue groups across the U.S. band together to rescue 4,000 beagles
Several animal rescue organizations across the U.S. are racing against the clock to rehome approximately 4,000 beagles from a research facility in Virgina. The Humane Society of the United States is working with the U.S. Justice Department in spearheading the effort to transfer these dogs from their current home to shelters in a marrer of weeks. The Envigo facility, which bred these beagles for pharmaceutical testing and research, was found to be in violation of several federal regulations. The beagles were found this year in horrendous condition, according to U.S. Agriculture Department reports.
USA Today (July 13, 2022) 4,000 Beagles to be rescued from Envigo breeding facility after animal welfare violations
A federal judge approved the transfer of 4,000 beagles hosed at a Virginia breeding facility to shelters where they can be adopted.
CNN (July 12, 2022) 4,000 beagles will be rescued from a Virginia breeding facility
The Human Society of the United States (HSUS) will transfer 4,000 beagles from a research facility in Cumberland, Virginia, to human societies across the United States where they can be adopted, under a plan approved by a federal judge last week. A series of inspections over the course of nine months found more that 70 animal welfare violations at the Envigo breeding facility.
The Hill (July 12, 2022) Authorities are trying to find homes for 4,000 beagles rescued from Virginia facility
The nonprofit Humane Society of the United States will remove the beagles over a 60-day period and subsequently transfer them to animal shelters and rescue organizations, according to the approved plan.
Pharma Phorum (July 8, 2022) Pharma’s spend on AI in drug discovery ‘could top $3bn by 2025’
The pharmaceutical industry is increasingly relying on artificial intelligence to power its drug discovery and development efforts, and its spend in this area has created a multibillion-dollar market for AI technologies. That’s the conclusion of a GlobalData report, which notes that AI is being used to enhance computer-aided drug design (CADD) in a bid to reduce the time and costs involved in getting a new drug to market.
- You must be logged in to reply to this topic.